Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Angiotensinogen, Angiotensin-Converting Enzyme, and Chymase Gene Polymorphisms as Biomarkers for Basal Cell Carcinoma Susceptibility.

Advances in experimental medicine and biology - 1 Jan 2023

Yapijakis Christos, Gintoni Iphigenia, Charalampidou Sevastiana, Angelopoulou Antonia, Papakosta Veronica, Vassiliou Stavros, Chrousos George P

Abstract excerpt

INTRODUCTION: The intake of angiotensin-converting enzyme (ACE) inhibitors and specific antagonists of angiotensin II receptors, widely used as antihypertensive drugs, significantly reduces the risk of developing basal cell carcinoma (BCC), highlighting the possible tumorigenic role of angiotensin II (AngII). We present here the investigated genetic association between the development of BCC and functional DNA...

Topics

Join the communities discussing this publication.

Angiotensin II
Angiotensinogen
Carcinoma, Basal Cell
Chymases
Peptidyl-Dipeptidase A

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Renin-Angiotensin System

Serine Proteases

Source

Identifiers

PMID: 37525041
DOI: 10.1007/978-3-031-31978-5_14

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Angiotensinogen, Angiotensin-Converting Enzyme, and Chymase Gene Polymorphisms as Biomarkers for Basal Cell Carcinoma Susceptibility.PMID 37525041Read ↗

Association Between a High Gene Expression Variant of Chymase and Increased Risk for Basal Cell Carcinoma.Semantic proximity Read ↗

Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with decreased risk for basal cell carcinoma.Semantic proximity Read ↗

Lack of Association Between the ACE2 G8790A Gene Variation and Risk for Basal Cell Carcinoma.Semantic proximity Read ↗

Association study indicates combined effect of interleukin-10 and angiotensin-converting enzyme in basal cell carcinoma development.Semantic proximity Read ↗

Angiotensin Converting Enzyme (ACE) insertion/deletion (rs1799752) gene polymorphism and bladder cancer aggressiveness in Egyptian patients: A pilot case-control study.Semantic proximity Read ↗

Association of AGTR1 (A1166C) and ACE (I/D) Polymorphisms with Breast Cancer Risk in North Indian PopulationSemantic proximity Read ↗

Genetic polymorphisms of the renin-angiotensin system in breast cancer patients.Semantic proximity Read ↗

Angiotensinogen polymorphism is associated with risk for malignancy but not for oral cancer.Semantic proximity Read ↗

Association between angiotensin I-converting enzyme gene polymorphism and susceptibility to cancer: a meta analysis.Semantic proximity Read ↗

Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with increased risk for oral cancer.Semantic proximity Read ↗

Polymorphisms in angiotensin II type 1 receptor and angiotensin I-converting enzyme genes and breast cancer risk among Chinese women in Singapore.Semantic proximity Read ↗

Influences of chymase and angiotensin I-converting enzyme gene polymorphisms on gastric cancer risks in Japan.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.